Addition of clindamycin to whole-cell cultures of Streptomyces coelicolor MUller resulted in the loss of in vitro activity against organisms sensitive to clindamycin. Incubation of such culture filtrates with alkaline phosphatase generated a biologically active material identified as clindamycin. Fermentation broths containing inactivated clindamycin yielded clindamycin 3-phosphate, the structure of which was established by physical-chemical and enzymatic studies. Clindamycin was phosphorylated by lysates and partially purified enzyme preparations from S. coelicolor MUller. These reactions require a ribonucleoside triphosphate and Mg2+. The product of the cell-free reactions was identified as clindamycin 3-phosphate.
Recent reports have described the inactivation of several aminoglycoside antibiotics by enzymatic phosphorylation (4-6, 8, 12, 13, 15, 16; R.E. Benveniste, B.R. Ozanne, and J. Davies, Bacteriol. Proc., p. 48, 1969). Such phosphorylating enzymes have been isolated from R-factorcarrying Escherichia coli strains and from strains of Staphylococcus aureus and Pseudomonas aeruginosa. Previously we reported the phosphorylation of lincomycin and several related antibiotics by a strain of Streptomyces rochei (1) . In further studies on the biomodification of antibiotics by actinomycetes, several species of streptomycetes also were found to be capable of inactivating clindamycin, the semisynthetic antibiotic produced by chlorination of lincomycin ( Fig. 1 ; reference 10). The present report describes the phosphorylation of clindamycin by whole cells and by cell-free extracts of Streptomyces coelicolor MUller and the isolation and determination of the structure of the product. 6 -cm stroke). Clindamycin hydrochloride (50 ug/ml) was added after 24 hr. Culture filtrates were harvested after 48 hr of fermentation, at which time the added clindamycin was found to be completely inactivated.
Isolation of clindamycin 3-phosphate. Fermentation broth (about 12 liters) containing inactivated clindamycin was filtered at harvest pH (6.5) by using Dicalite filter aid, type 4200 (Johns-Manville Co., New York, N.Y.). The mycelial cake was washed with water and discarded. The clear filtrate and the wash were pooled and passed over a column prepared from 600 g of Amberlite, XAD-2 ion-exchange resin (Rohm and Haas Co., Philadelphia, Pa.). The column then was washed with 2 liters of water. Both column effluent and aqueous wash were inactive when tested against S. lutea before and after treatment with alkaline phosphatase. Elution of the column with 60% aqueous methanol yielded fractions containing clindamycin 3-phosphate in mixture with small amounts of unidentified compounds that also yielded clindamycin when incubated with alkaline phosphatase. These fractions were combined.
Purification by chromatography. A column was prepared from 400-ml of Dowex- Purification by countercurrent distribution. The solvent system for further purification consists of equal volumes of 1-butanol and water. The starting material, 2.59 g of impure clindamycin 3-phosphate (obtained as described above), was dissolved in both phases of the solvent system, and this solution was introduced into 10 tubes of an all-glass countercurrent distribution apparatus (Craig). The distribution was carried for 500 transfers. The solution then was analyzed by determination of activity against S. lutea before and after treatment with alkaline phosphatase. Fractions 200 to 300, found to contain clindamycin phosphate, were concentrated to dryness in vacuo. The residue was dissolved in 5 ml of methanol, and this solution was mixed with 20 ml of acetone and 100 ml of ether. The precipitated colorless clindamycin 3-phosphate was isolated by filtration and dried, yielding 300 mg.
Culture conditions for phosphorylation of clindamycin by cell-free extracts. For the preparation of cell-free extracts of S. coelicolor MUller, the fermentation medium given above was inoculated with 5% (v/v) of 72-hr seed culture prepared as described, and cultures were incubated for 24 hr at 28 C on a rotary shaker. Cells were harvested and washed twice in Spizizen's mineral salts medium (14) .
Assay Further purification of the enzyme was obtained by diethylaminoethyl cellulose chromatography. Diethylaminoethyl cellulose (Cellex, type D; Bio-Rad Laboratories, Richmond, Calif.) was washed sequentially with 0.5 N HCI, distilled water, 0.5 N NaOH, and 0.02 M KPO buffer, pH 7.5, after which a column (20 by 127 mm) was prepared. A 200-ml portion of crude lysate was treated with manganese chloride and ammonium sulfate as described above, and the precipitate from the 60% ammonium sulfate treatment was suspended in a final volume of 10 ml. A 7-ml amount of this fraction was applied to the column and washed in with 75 ml of 0.02 M KPO, buffer, pH 7.5. Fractions (75 ml) of buffers containing KCI in 0.05 M increments ranging from 0.05 to 0.3 M were added to the column, and 5-ml fractions were collected. The column fractions were assayed for clindamycin-phosphorylating enzyme in the reaction mixture described above, with only 0.01 rather than 0.05 ,umole of clindamycin in each 1 -ml reaction volume. The reaction tubes were sampled after 5 hr of incubation in a water bath at 30 C. Samples were tested by disc-plate assay for inhibition of the growth of S. lutea. Tubes containing clindamycin-inactivating enzyme were pooled (volume, 30 ml), and the protein was precipitated by adding ammonium sulfate to give 60% saturation. The precipitate was suspended in 5 ml of 0.02 M potassium phosphate buffer (pH 7.5) for assay, and was stored above liquid nitrogen.
A two-to threefold purification of one crude enzyme preparation resulted from treatment of the lysate with MnCl, and ammonium sulfate fractionation (Table 1) . Nearly one-half of the total starting activity, however, was lost by this procedure. After diethylaminoethyl cellulose chromatography, the preparation showed a 41-fold increase in specific activity over the starting crude lysate but contained only approximately 4% of the total enzyme present in the crude lysate.
RESULTS
Characterization and structure of product of whole-cell inactivation of clindamycin. Inactivated clindamycin was extracted from filtered S. coelicolor beer by adsorption on Amberlite +930 (c, 0.925). The infrared spectrum in Nujol mull showed broad absorptions at 3,300 to 3,055 cm-1 and at 2,720 to 2,680 cm-1. The presence of an amide carbonyl grouping is indicated by strong absorptions at 1,685 to 1,675 cm-I (amide I) and at 1,555 to 1,532 cm-1 (amide II). The ultraviolet spectrum showed no absorption between 200 and 400 nm.
Treatment of the inactivated clindamycin with either snake venom or spleen phosphodiesterase did not restore antibiotic activity. However, when the obtained material was incubated with alkaline phosphatase, clindamycin was detected as a product of the enzymatic hydrolysis.
The molecular formula of the isolated compound, the molecular rotation ([MID, +458°), and the infrared spectrum indicated a clindamycin-related material. The lack of in vitro activity, the presence of one phosphorus atom per molecule, and the production of clindamycin by treatment with alkaline phosphatase suggested that phosphorus was present as part of a phosphate ester. The possibility of a cyclic phosphate diester system was excluded by the data obtained by potentiometric titration. The isolated clinda- identical to those found for chemically prepared clindamycin 2-phosphate. The nuclear magnetic resonance spectrum (Fig. 2) of the microbiologically phosphorylated clindamycin was identical to the spectrum of clindamycin in all areas except the carbinol hydrogen and anomeric hydrogen regions [specifically, the unsymmetrical absorption (3 H) at 6, 0.8 ppm (C-CH3 at C-4' of the amino acid moiety)]. The doublet at about 6, 1.3 ppm (CH3 CH-of the amino sugar part) and the sharp singlets at 6, 2.05 ppm (-SCH3) and 2.85 ppm (NCH3) are present in the spectra of both clindamycin and the phosphorylated clindamycin. The main differences between the spectra of these compounds are in the areas assigned to the carbinol hydrogen (6, 3.1 to 4.5 ppm) and the anomeric hydrogen (6, 5.2 to 5.6 ppm). This indicates that the phosphate group is attached to carbon 2, 3, or 4 of the amino sugar moiety of the clindamycin molecule (Fig. 1) .
The microbiologically produced clindamycin phosphate was compared with and differentiated from clindamycin 2-phosphate by nuclear magnetic resonance spectroscopy and by thin-layer chromatography. This procedure revealed carbon 3 or 4 of the sugar moiety of the clindamycin molecule as the possible point of attachment of the phosphate-ester grouping. The clindamycin 3- phosphate structure that we propose is based on comparison of the nuclear magnetic resonance spectrum with the spectrum of the isolated clindamycin phosphate of lincomycin 3-phosphate, which we reported previously (1) . In the spectra of both compounds, the anomeric hydrogen appeared as a doublet (j = 5.5 cycles per sec) at 6, 5.3. In addition, the downfield shift of the signal of the anomeric hydrogen in both lincomycin 3- phosphate and clindamycin 3-phosphate was identical to the chemical shift of the respective parent compounds indicating location of the phosphate group at the same carbon (C-3) of the amino sugar moiety of these closely related antibiotics.
Characterization of product of cell-free inactivation of clindamycin. The product of the cellfree inactivation of clindamycin was determined to be clindamycin 3-phosphate by alkaline phosphatase hydrolysis and by thin-layer chromatography comparison with clindamycin 3-phosphate that was isolated and characterized from the whole-cell inactivation of clindamycin.
Stoichiometry of reaction. The ATP clindamycin stoichiometry would be expected to be mole for mole in the reaction, as reported by Doi et al. (4) of antibiotic phosphorylating enzymes from bacteria. In our reaction, optimum phosphorylation was obtained with a large excess of ATP over clindamycin. This may be explained by the fact that the enzyme preparation still had marked adenosine triphosphatase -activity after ammonium sulfate fractionation.
Effect of temperature. The effect of incubation temperature on the reaction rate was determined by two experimental procedures. In the first procedure, reaction mixtures incubated at different temperatures were assayed for loss of clindamycin activity at 10-min intervals over a 60-min pe- (Fig.  3) . It displayed greater initial activity at 37 C than at 30 C, but it was inactivated readily at the higher temperature.
Effectiveness of nucleotides other than ATP. Equimolar concentrations of guanosine triphosphate, cytidine triphosphate, uridine triphosphate, and adenosine diphosphate were compared with ATP in the clindamycin phosphorylation reaction. The results of one such experiment, carried out with enzyme purified through the diethylaminoethyl cellulose chromatography step, are shown in Fig. 4 . Phosphorylation proceeded in all instances, but the rate observed with ATP was much more rapid than any obtained with the other nucleotides tested. DISCUSSION Several species of streptomycetes have been shown to phosphorylate clindamycin. As reported previously, S. rochei phosphorylates lincomycin, yielding lincomycin 3-phosphate (1). This species also phosphorylates clindamycin, but less efficiently than does the S. coelicolor strain described. Also, streptomycetes have been found that transform clindamycin to clindamycin sulfoxide and 1'-demethylclindamycin (2) . The S. coelicolor clindamycin phosphorylation reaction resembles those described for the phosphorylation of aminoglycoside antibiotics by enzymes isolated from R-factor carrying E. coli strains and Pseudomonas strains. It is especially interesting to note that the products of phospho- rylation of both clindamycin and the aminoglycoside antibiotics are 3-phosphates. The E. coli enzymes phosphorylate neomycin, kanamycin, paromamine, and streptomycin at the three position of one of the amino hexose moieties; in a similar manner, S. coelicolor phosphorylates clindamycin at the three position of the amino sugar. The clindamycin-phosphorylating enzyme is not effective, however, in phosphorylating streptomycin, neomycin, kanamycin, or bluensomycin.
The relative ability of guanine triphosphate, uridine triphosphate, cytidine triphosphate, and adenosine diphosphate to substitute for ATP in the clindamycin phosphorylation reaction almost duplicates that found by Doi et al. (6) with the kanamycin-phosphorylating enzyme from P. aeruginosa. However, Doi et al. (4) found that, in reactions with the kanamycin-phosphorylating enzyme from E. coli, these nucleotides could be substituted for ATP only when fairly crude enzyme preparations were employed. As the enzyme was purified, an absolute requirement for ATP was demonstrated. A similar specificity might be demonstrated with the S. coelicolor enzyme upon further purification.
